Fundz

Vir Biotechnology Secures $140.4 Million in Common Stock Offering

PUBLIC · VIRNov 16, 2026

Amount Raised

$140 Million

Round Type

Post-IPO Equity

San FranciscoBiotechnology

Investors

Evercore Group L.L.C.Morgan Stanley & Co. LLCLeerink Partners LLC

Description

On November 12, 2026, Vir Biotechnology, Inc. entered into an underwriting agreement for the sale of 15 million shares of common stock at $10.00 per share. The offering is expected to close on November 16, 2026, subject to customary conditions. With the option for underwriters to purchase additional shares, total proceeds could reach approximately $161.5 million.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Vir Biotechnology, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Rezolute raised $94M (Post-IPO Equity) on November 16, 2026.
  • Raywatt raised $9.9M (Series B) on November 16, 2026.
  • Seawolf Therapeutics raised $100M (Seed) on November 16, 2026.
  • 201 Therapeutics raised $178K (Seed) on November 16, 2026.
  • Boston Medical Sciences raised $35M (Series B) on November 13, 2026.
  • Lifeplex Science raised $5.3M (Series A) on November 13, 2026.

Who to call at Vir Biotechnology, Inc., and when

A new round usually means Vir Biotechnology, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vir Biotechnology, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vir Biotechnology, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vir Biotechnology, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vir Biotechnology, Inc.

Location

1800 Owens Street

San Francisco, California, United States

About

Vir Biotechnology brings together cutting-edge innovations with scientific expertise and management.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vir Biotechnology, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts44 people are listed at Vir Biotechnology, Inc.. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Vir Biotechnology, Inc.'s next move

See what Strategic adds

Vir Biotechnology, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.